Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01816932 · ClinicalTrials.gov registry record · NA

Home or Office Visit for the Insertion of Implantable Birth Control

A NA study of Contraception, sponsored by Case Western Reserve University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01816932 is a NA study of Contraception that has completed, run by Case Western Reserve University. The registered enrollment target is 40 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01816932, a NA study of Contraception, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study in which women who desire an etonogestrel implant will be randomized to either a home or office insertion visit. The purpose of this research is to study the interest in, feasibility of, and rates of insertion for implantable birth control (Implanon®/Nexplanon®) when inserted at home visit appointments compared to standard office visit appointments. The ultimate goal of the study is to reduce barriers to insertion of the etonogestrel implant and increase consistent and correct contraception use by introducing a previously unexplored method of access, the home visit.

Conditions Studied

Interventions

  • PROCEDURE Home Visit
  • PROCEDURE Office visit

Study Locations (1)

Ohio

  • University Hospitals - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2013-06
Est. Completion 2014-02
Phase NA

Sponsor

Case Western Reserve University

141 total trials

What the Registry Record Tells You About NCT01816932

The ClinicalTrials.gov registry entry for NCT01816932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (91% lower). The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 2 interventions - of which Home Visit is the first listed.

NCT01816932 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01816932 about?

NCT01816932 is a clinical study titled "Home or Office Visit for the Insertion of Implantable Birth Control". This is a pilot study in which women who desire an etonogestrel implant will be randomized to either a home or office insertion visit. The purpose of this research is to study the interest in, feasibility of, and rates of insertion for implantable birth control (Implanon®/Nexplanon®) when inserted a...

What is the current status of trial NCT01816932?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-06. Estimated completion is 2014-02.

What conditions does trial NCT01816932 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT01816932?

The interventions under investigation include: Home Visit (PROCEDURE), Office visit (PROCEDURE).

Who is sponsoring clinical trial NCT01816932?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01816932 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.